Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Nov;35(11):3004–3006. doi: 10.1128/jcm.35.11.3004-3006.1997

Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.

S L Pendland 1, S J Martin 1, C Chen 1, P C Schreckenberger 1, L H Danziger 1
PMCID: PMC230109  PMID: 9350781

Abstract

We compared growth characteristics of 46 Legionella strains grown on buffered charcoal yeast extract alpha (BCYE alpha) agar and buffered starch yeast extract (BSYE) agar and MICs of macrolides, azalides, and fluoroquinolones for these organisms. Growth was poor and not reproducible on BSYE agar. Growth was excellent on BCYE alpha, and MICs were easy to interpret. BCYE alpha is superior to BSYE for testing susceptibilities of Legionella species by agar dilution.

Full Text

The Full Text of this article is available as a PDF (190.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker J., Farrell I. D. The effect of charcoal on MICs for Legionella. J Antimicrob Chemother. 1986 Jan;17(1):127–127. doi: 10.1093/jac/17.1.127. [DOI] [PubMed] [Google Scholar]
  2. Bornstein N., Roudier C., Fleurette J. Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media. J Antimicrob Chemother. 1985 Jan;15(1):17–22. doi: 10.1093/jac/15.1.17. [DOI] [PubMed] [Google Scholar]
  3. Chen S. C., Paul M. L., Gilbert G. L. Susceptibility of Legionella species to antimicrobial agents. Pathology. 1993 Apr;25(2):180–183. doi: 10.3109/00313029309084795. [DOI] [PubMed] [Google Scholar]
  4. Collins L. A., Wennersten C. B., Ferraro M. J., Moellering R. C., Jr, Eliopoulos G. M. Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp. Antimicrob Agents Chemother. 1994 Jan;38(1):144–146. doi: 10.1128/aac.38.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dubois J., Joly J. R. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp. J Antimicrob Chemother. 1992 Jul;30 (Suppl A):77–81. doi: 10.1093/jac/30.suppl_a.77. [DOI] [PubMed] [Google Scholar]
  6. Edelstein P. H., Edelstein M. A. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages. Antimicrob Agents Chemother. 1989 Dec;33(12):2132–2136. doi: 10.1128/aac.33.12.2132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson D. M., Erwin M. E., Barrett M. S., Gooding B. B., Jones R. N. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species. Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):751–755. doi: 10.1007/BF01989985. [DOI] [PubMed] [Google Scholar]
  8. Jones R. N. Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella spp. J Antimicrob Chemother. 1991 Mar;27(3):389–390. doi: 10.1093/jac/27.3.389. [DOI] [PubMed] [Google Scholar]
  9. Jones R. N., Erwin M. E., Barrett M. S. In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species. Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):846–848. doi: 10.1007/BF01967390. [DOI] [PubMed] [Google Scholar]
  10. Kitsukawa K., Hara J., Saito A. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents. J Antimicrob Chemother. 1991 Mar;27(3):343–353. doi: 10.1093/jac/27.3.343. [DOI] [PubMed] [Google Scholar]
  11. Liebers D. M., Baltch A. L., Smith R. P., Hammer M. C., Conroy J. V. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. J Antimicrob Chemother. 1989 Jan;23(1):37–41. doi: 10.1093/jac/23.1.37. [DOI] [PubMed] [Google Scholar]
  12. Moffie B. G., Mouton R. P. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics. J Antimicrob Chemother. 1988 Oct;22(4):457–462. doi: 10.1093/jac/22.4.457. [DOI] [PubMed] [Google Scholar]
  13. Pasculle A. W., Dowling J. N., Weyant R. S., Sniffen J. M., Cordes L. G., Gorman G. M., Feeley J. C. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents. Antimicrob Agents Chemother. 1981 Dec;20(6):793–799. doi: 10.1128/aac.20.6.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pasculle A. W., Feeley J. C., Gibson R. J., Cordes L. G., Myerowitz R. L., Patton C. M., Gorman G. W., Carmack C. L., Ezzell J. W., Dowling J. N. Pittsburgh pneumonia agent: direct isolation from human lung tissue. J Infect Dis. 1980 Jun;141(6):727–732. doi: 10.1093/infdis/141.6.727. [DOI] [PubMed] [Google Scholar]
  15. Rhomberg P. R., Bale M. J., Jones R. N. Application of the Etest to antimicrobial susceptibility testing of Legionella spp. Diagn Microbiol Infect Dis. 1994 Jul;19(3):175–178. doi: 10.1016/0732-8893(94)90063-9. [DOI] [PubMed] [Google Scholar]
  16. Saito A., Koga H., Shigeno H., Watanabe K., Mori K., Kohno S., Shigeno Y., Suzuyama Y., Yamaguchi K., Hirota M. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. J Antimicrob Chemother. 1986 Aug;18(2):251–260. doi: 10.1093/jac/18.2.251. [DOI] [PubMed] [Google Scholar]
  17. Saito A., Sawatari K., Fukuda Y., Nagasawa M., Koga H., Tomonaga A., Nakazato H., Fujita K., Shigeno Y., Suzuyama Y. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs. Antimicrob Agents Chemother. 1985 Jul;28(1):15–20. doi: 10.1128/aac.28.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES